Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.451 USD | -1.96% | -6.45% | -22.93% |
05-15 | Lumos Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Transcript : Lumos Pharma, Inc., Q1 2024 Earnings Call, May 15, 2024 |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
19.89M | - | - | - | |||
63.85B | - | |||||
41.83B | ||||||
40.47B | ||||||
27.17B | ||||||
26.52B |
- Stock Market
- Equities
- LUMO Stock
- Charts Lumos Pharma, Inc.
- Sector Chart